Anixa Biosciences, Inc. (ANIX) Key Metrics
ANIX valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $92.8M
- Enterprise value
- $82.3M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 377.8 10-yr median 185.0
- Price / book
- 6.7 10-yr median 5.7
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.48
ANIX key metrics, FY2016–FY2025
Fiscal year ended October 31, 2025 · U.S. dollarsANIX valuation Price multiples at each fiscal year-end price.
Price / book+58.4%
8.8
FY2025 · hover or tap a bar for each year
FY2016FY2025
Free cash flow yield+1.2 pts
−5.4%
FY2025 · hover or tap a bar for each year
FY2016FY2025
ANIX returns How much profit the business earns on the capital it uses.
Return on equity−5.5 pts
−62.2%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Return on assets−4.7 pts
−58.0%
FY2025 · hover or tap a bar for each year
FY2016FY2025
Asset turnover
0.00
FY2025 · hover or tap a bar for each year
FY2016FY2025
ANIX per-share figures Results divided by the shares outstanding at year-end.
Revenue per share
$0.00
FY2025 · hover or tap a bar for each year
FY2016FY2025
Earnings per share
−$0.34
FY2025 · hover or tap a bar for each year
FY2016FY2025
Free cash flow per share
−$0.22
FY2025 · hover or tap a bar for each year
FY2016FY2025
Book value per share−25.5%
$0.47
FY2025 · hover or tap a bar for each year
FY2016FY2025
Shares outstanding+1.7%
32.5M
FY2025 · hover or tap a bar for each year
FY2016FY2025
ANIX financial health Debt, liquidity and how easily interest is covered.
Debt / equity+16.0%
0.01
FY2025 · hover or tap a bar for each year
FY2016FY2025
Net debt+$4.7M
−$15.0M
FY2025 · hover or tap a bar for each year
FY2016FY2025
Current ratio−5.5%
8.08
FY2025 · hover or tap a bar for each year
FY2016FY2025
Debt / assets+18.1%
0.01
FY2025 · hover or tap a bar for each year
FY2016FY2025
ANIX efficiency & capital use Working capital cycle and where the cash goes.
Days payables outstanding−108 days
3,498 days
FY2025 · hover or tap a bar for each year
FY2016FY2025
ANIX valuation history
Fiscal year-endToday10-year median
ANIX returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
ANIX debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
ANIX cash returned to shareholders
DividendsBuybacksFree cash flow
ANIX price vs earnings per share
Share price at year-endEPS (right axis)
ANIX key metrics
FY2016–FY2025| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $134.0M | $111.6M | $97.9M | $170.1M | $136.3M | $45.8M | $76.6M | $71.4M | $25.0M | $55.5M |
| Enterprise value | $119.1M | $92.0M | $74.2M | $140.6M | $100.9M | $36.8M | $70.7M | $66.3M | $18.2M | $56.4M |
| Price / sales | — | — | 466.2 | 0.1 | 266.3 | — | 306.3 | 64.2 | 69.0 | 185.0 |
| Price / book | 8.8 | 5.6 | 4.0 | 5.9 | 3.8 | 5.2 | 14.6 | 13.1 | 3.2 | 56.2 |
| EV / sales | — | — | 353.5 | 0.1 | 197.0 | — | 283.0 | 59.6 | 50.1 | 188.1 |
| Earnings yield | −8.2% | −11.2% | −10.0% | −8.0% | −9.5% | −22.1% | −15.2% | −19.6% | −20.0% | −9.0% |
| Free cash flow yield | −5.4% | −6.6% | −6.3% | −3.8% | −3.6% | −13.5% | −6.4% | −6.0% | −15.3% | −6.4% |
| Dividend yield | — | — | — | — | — | — | — | 0.0% | 0.0% | — |
| Shareholder yield (dividends + buybacks) | 0.0% | 0.0% | 0.0% | 0.0% | — | 0.0% | 0.0% | 0.0% | 2.0% | 0.0% |
| Share price at fiscal year-end | $4.13 | $3.50 | $3.16 | $5.60 | $4.77 | $2.06 | $3.87 | $4.05 | $2.05 | $6.35 |
| Per share | ||||||||||
| Revenue per share | $0.00 | $0.00 | $0.01 | $81.29 | $0.02 | $0.00 | $0.01 | $0.06 | $0.03 | $0.03 |
| Earnings per share | −$0.34 | −$0.39 | −$0.32 | −$0.45 | −$0.45 | −$0.46 | −$0.59 | −$0.79 | −$0.41 | −$0.57 |
| Operating cash flow per share | −$0.22 | −$0.23 | −$0.20 | −$0.21 | −$0.17 | −$0.28 | −$0.24 | −$0.24 | −$0.31 | −$0.39 |
| Free cash flow per share | −$0.22 | −$0.23 | −$0.20 | −$0.21 | −$0.17 | −$0.28 | −$0.25 | −$0.24 | −$0.31 | −$0.40 |
| Cash per share | $0.47 | $0.62 | $0.77 | $0.98 | $1.25 | $0.41 | $0.30 | $0.29 | $0.56 | $0.37 |
| Book value per share | $0.47 | $0.63 | $0.79 | $0.96 | $1.24 | $0.39 | $0.26 | $0.31 | $0.65 | $0.11 |
| Tangible book value per share | $0.47 | $0.63 | $0.79 | $0.96 | $1.24 | $0.39 | $0.26 | $0.26 | $0.51 | −$0.12 |
| Dividends per share | — | — | — | — | — | — | — | $0.00 | $0.00 | — |
| Capex per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.02 |
| Debt per share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.00 | — | $0.00 | $0.00 | $0.48 |
| Shares outstanding | 32.5M | 31.9M | 31.0M | 30.4M | 28.6M | 22.2M | 19.8M | 17.6M | 12.2M | 8.7M |
| Change in shares outstanding | +1.7% | +3.0% | +2.0% | +6.3% | +28.6% | +12.3% | +12.3% | +44.5% | +39.6% | −9.2% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −62.2% | −56.6% | −36.8% | −42.2% | −58.6% | −144.8% | −218.3% | −209.6% | −112.4% | −166.1% |
| Return on invested capital (ROIC) | — | — | — | — | — | — | — | — | −319.5% | — |
| Return on assets (ROA) | −58.0% | −53.3% | −35.1% | −40.8% | −56.6% | −128.7% | −182.8% | −183.4% | −69.4% | −67.0% |
| Return on tangible assets | −68.0% | −58.1% | −38.4% | −44.7% | −35.7% | −107.2% | −185.1% | −249.4% | −70.9% | −141.0% |
| Free cash flow margin | — | — | — | −0.3% | −964.5% | — | — | −387.6% | — | — |
| Financial health | ||||||||||
| Total debt | $204,000 | $232,000 | $175,000 | $221,000 | $259,000 | $55,198 | — | $0 | $0 | $4.2M |
| Cash & short-term investments | $15.2M | $19.9M | $23.8M | $29.7M | $35.7M | $9.1M | $5.8M | $5.1M | $6.8M | $3.2M |
| Net debt | −$15.0M | −$19.7M | −$23.7M | −$29.5M | −$35.5M | −$9.0M | −$5.8M | −$5.1M | −$6.8M | $933,553 |
| Debt / equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | — | 0.00 | 0.00 | 4.22 |
| Debt / assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | — | 0.00 | 0.00 | 0.74 |
| Current ratio | 8.08 | 8.54 | 12.50 | 14.83 | 28.35 | 7.88 | 4.11 | 4.38 | 7.89 | 7.25 |
| Quick ratio | 8.08 | 8.54 | 12.50 | 14.85 | 28.35 | 10.10 | 5.70 | 4.38 | 7.89 | 7.25 |
| Interest coverage | — | — | — | -133.4 | — | -294.1 | — | — | -12.1 | -8.7 |
| Working capital | $13.9M | $18.9M | $23.3M | $28.2M | $34.7M | $8.2M | $4.6M | $4.3M | $6.1M | $2.9M |
| Invested capital | $191,000 | $306,000 | $668,000 | −$419,000 | −$31,593 | −$240,507 | −$606,272 | $378,918 | $1.1M | $1.9M |
| Tangible asset value | $13.9M | $18.9M | $23.4M | $28.2M | $34.8M | $8.3M | $4.8M | $4.3M | $6.2M | −$1.1M |
| Net current asset value | $13.8M | $18.7M | $23.2M | $28.0M | $34.5M | $8.2M | $4.6M | $4.3M | $6.1M | −$1.2M |
| Graham net-net per share | $0.40 | $0.54 | $0.71 | $0.90 | $1.20 | $0.29 | $0.16 | $0.23 | $0.49 | −$0.16 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | — | $0 | $0 | — |
| Share buybacks (net) | $0 | $6,000 | $0 | $0 | — | $0 | $0 | $0 | $500,000 | $0 |
| Capex / revenue | — | — | 0.0% | 0.0% | 0.0% | — | 70.2% | 3.5% | 8.3% | 48.8% |
| Capex / depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 | 0.38 | 0.11 | 0.08 | 0.41 |
| Stock-based compensation / revenue | — | — | 2,105.7% | 0.2% | 1,465.4% | — | 2,206.1% | 771.0% | 461.6% | 291.2% |
| R&D / revenue | — | — | 2,271.0% | 0.3% | 1,208.9% | — | 2,189.4% | 612.4% | 440.7% | 518.8% |
| SG&A / revenue | — | — | 2,995.7% | 0.3% | 1,381.5% | — | 2,265.1% | 621.3% | 1,216.7% | 903.3% |
| Efficiency | ||||||||||
| Days sales outstanding | — | — | 274.6 | 0.0 | — | — | 272.7 | 100.7 | — | — |
| Days of inventory on hand | — | — | — | -399.8 | — | -10,101.0 | -2,579.7 | 0.0 | — | — |
| Days payables outstanding | 3,497.9 | 3,605.6 | 533.9 | 1,742.4 | 174.6 | 1,656.2 | 1,282.0 | 177.3 | 1,489.8 | 627.8 |
| Cash conversion cycle (days) | — | — | -259.3 | -2,142.2 | — | — | -3,589.0 | -76.5 | — | — |
| Receivables turnover | 0.00 | 0.00 | 1.33 | 53,673.91 | — | 0.00 | 1.34 | 3.62 | — | — |
| Payables turnover | 0.10 | 0.10 | 0.68 | 0.21 | 2.09 | 0.22 | 0.28 | 2.06 | 0.24 | 0.58 |
| Inventory turnover | — | — | — | — | — | — | — | 2,187,412.00 | — | — |
| Asset turnover | 0.00 | 0.00 | 0.01 | 74.07 | 0.02 | 0.00 | 0.04 | 0.15 | 0.05 | 0.04 |
| Average receivables | $86,500 | $221,500 | $158,000 | $46,000 | — | $34,379 | $186,759 | $306,991 | — | — |
| Average payables | $345,000 | $365,500 | $235,500 | $200,500 | $184,184 | $409,092 | $583,914 | $531,168 | $426,774 | $373,964 |
| Average inventory | — | — | — | −$46,000 | — | −$2.5M | −$1.2M | $0 | $0 | — |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 13.0% | 19.8% | 36.8% |
Computed from ANIX's annual financial statements (latest annual report filed January 12, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
ANIX valuation and financial ratios
Anixa Biosciences earned a return on equity of −62.2% in fiscal 2025. It ended the year with $0.2 million of debt and $15.2 million in cash and short-term investments, a net cash position of $15.0 million. The share count rose 271.4% from 8.7M to 32.5M over 9 years.
See the ANIX income statement, the ANIX chart for price history, or the ANIX stock overview for the latest quote and news.
ANIX key metrics FAQ
What is Anixa Biosciences's return on equity?
Anixa Biosciences's return on equity (ROE) was −62.2% in fiscal 2025: net income of -$10.9 million on average shareholders' equity of $17.6 million.
How much debt does Anixa Biosciences have?
Anixa Biosciences had total debt of $0.2 million at the end of fiscal 2025, a debt-to-equity ratio of 0.01 and more cash than debt.
What is Anixa Biosciences's free cash flow yield?
Anixa Biosciences generated -$7.2 million of free cash flow in fiscal 2025, a free cash flow yield of −5.4% on its market value at year-end ($134.0 million).
What is Anixa Biosciences's current ratio?
Anixa Biosciences's current ratio was 8.08 at the end of fiscal 2025: current assets were 8.08 times current liabilities.